Literature DB >> 20083118

cAMP-independent activation of protein kinase A by the peroxynitrite generator SIN-1 elicits positive inotropic effects in cardiomyocytes.

Mark J Kohr1, Christopher J Traynham, Steve R Roof, Jonathan P Davis, Mark T Ziolo.   

Abstract

The phosphatase vs. kinase equilibrium plays a critical role in the regulation of myocardial contractility. Previous studies have demonstrated that peroxynitrite exerts a biphasic effect on cardiomyocyte contraction, such that high peroxynitrite reduced beta-adrenergic-stimulated myocyte contraction by inducing the dephosphorylation of phospholamban (PLB) via phosphatase activation. Conversely, low peroxynitrite increased basal and beta-adrenergic-stimulated contraction also through a PLB-dependent mechanism. However, previous studies have not elucidated the mechanism underlying the positive effects of low peroxynitrite on myocyte contraction. In the current study, we examined the phosphatase vs. kinase equilibrium as a potential mechanism underlying the positive effects of peroxynitrite. SIN-1 (peroxynitrite donor, 10 mumol/L) increased myocyte Ca(2+) transient and shortening amplitude, accelerated myocyte relaxation, and enhanced PLB phosphorylation. Specific inhibition of PP1/PP2a with okadaic acid failed to inhibit this positive effect. However, inhibition of PKA with KT5720 completely abolished the effects of SIN-1 on myocyte contraction. Additionally, SIN-1 induced a significant increase in PKA activity in cardiac homogenates, which was inhibited with FeTPPS (peroxynitrite decomposition catalyst). Surprisingly, SIN-1 also increased activity in purified preparations (i.e., in the absence of cAMP) of PKA. Therefore, our data suggest that peroxynitrite directly activates PKA (independent from cAMP), resulting in the enhancement of myocyte contraction and relaxation through the phosphorylation of PLB. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20083118      PMCID: PMC2837779          DOI: 10.1016/j.yjmcc.2010.01.007

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  12 in total

1.  When is cAMP not cAMP? Effects of compartmentalization.

Authors:  D M Bers; M T Ziolo
Journal:  Circ Res       Date:  2001-08-31       Impact factor: 17.367

2.  Biphasic effect of SIN-1 is reliant upon cardiomyocyte contractile state.

Authors:  Mark J Kohr; Honglan Wang; Debra G Wheeler; Murugesan Velayutham; Jay L Zweier; Mark T Ziolo
Journal:  Free Radic Biol Med       Date:  2008-04-04       Impact factor: 7.376

3.  Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols.

Authors:  D L Campbell; J S Stamler; H C Strauss
Journal:  J Gen Physiol       Date:  1996-10       Impact factor: 4.086

4.  cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation.

Authors:  N Paolocci; U E Ekelund; T Isoda; M Ozaki; K Vandegaer; D Georgakopoulos; R W Harrison; D A Kass; J M Hare
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-10       Impact factor: 4.733

5.  Peroxynitrite Increases Protein Phosphatase Activity and Promotes the Interaction of Phospholamban with Protein Phosphatase 2a in the Myocardium.

Authors:  Mark J Kohr; Jonathan P Davis; Mark T Ziolo
Journal:  Nitric Oxide       Date:  2009-04-15       Impact factor: 4.427

6.  Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban.

Authors:  L K MacDougall; L R Jones; P Cohen
Journal:  Eur J Biochem       Date:  1991-03-28

7.  Targeting of phospholamban by peroxynitrite decreases beta-adrenergic stimulation in cardiomyocytes.

Authors:  Mark J Kohr; Honglan Wang; Debra G Wheeler; Murugesan Velayutham; Jay L Zweier; Mark T Ziolo
Journal:  Cardiovasc Res       Date:  2007-09-19       Impact factor: 10.787

8.  Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban.

Authors:  Honglan Wang; Mark J Kohr; Christopher J Traynham; Debra G Wheeler; Paul M L Janssen; Mark T Ziolo
Journal:  Am J Physiol Cell Physiol       Date:  2008-04-09       Impact factor: 4.249

Review 9.  Nitric oxide signaling and the regulation of myocardial function.

Authors:  Mark T Ziolo; Mark J Kohr; Honglan Wang
Journal:  J Mol Cell Cardiol       Date:  2008-08-03       Impact factor: 5.000

10.  Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation.

Authors:  Jonathan P Brennan; Sonya C Bardswell; Joseph R Burgoyne; William Fuller; Ewald Schröder; Robin Wait; Shajna Begum; Jonathan C Kentish; Philip Eaton
Journal:  J Biol Chem       Date:  2006-06-05       Impact factor: 5.157

View more
  14 in total

Review 1.  Abnormal Ca(2+) cycling in failing ventricular myocytes: role of NOS1-mediated nitroso-redox balance.

Authors:  Mark T Ziolo; Steven R Houser
Journal:  Antioxid Redox Signal       Date:  2014-08-07       Impact factor: 8.401

2.  Effects of increased systolic Ca²⁺ and phospholamban phosphorylation during β-adrenergic stimulation on Ca²⁺ transient kinetics in cardiac myocytes.

Authors:  Steve R Roof; Thomas R Shannon; Paul M L Janssen; Mark T Ziolo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-07-15       Impact factor: 4.733

3.  Obligatory role of neuronal nitric oxide synthase in the heart's antioxidant adaptation with exercise.

Authors:  Steve R Roof; Hsiang-Ting Ho; Sean C Little; Joseph E Ostler; Elizabeth A Brundage; Muthu Periasamy; Frederick A Villamena; Sandor Györke; Brandon J Biesiadecki; Christophe Heymes; Steven R Houser; Jonathan P Davis; Mark T Ziolo
Journal:  J Mol Cell Cardiol       Date:  2015-01-14       Impact factor: 5.000

4.  Peroxynitrite mediates testosterone-induced vasodilation of microvascular resistance vessels.

Authors:  Yashoda Puttabyatappa; John N Stallone; Adviye Ergul; Azza B El-Remessy; Sanjiv Kumar; Stephen Black; Maribeth Johnson; Mary P Owen; Richard E White
Journal:  J Pharmacol Exp Ther       Date:  2013-01-14       Impact factor: 4.030

5.  Neuronal nitric oxide synthase is indispensable for the cardiac adaptive effects of exercise.

Authors:  Steve R Roof; Lifei Tang; Joseph E Ostler; Muthu Periasamy; Sandor Györke; George E Billman; Mark T Ziolo
Journal:  Basic Res Cardiol       Date:  2013-02-04       Impact factor: 17.165

6.  Structural, functional, and mechanistic insights uncover the fundamental role of orphan connexin-62 in platelets.

Authors:  Khaled A Sahli; Gagan D Flora; Parvathy Sasikumar; Ali H Maghrabi; Lisa-Marie Holbrook; Sarah K AlOuda; Amro Elgheznawy; Tanya Sage; Alexander R Stainer; Recep Adiyaman; Mohammad AboHassan; Marilena Crescente; Neline Kriek; Sakthivel Vaiyapuri; Alexander P Bye; Amanda J Unsworth; Chris I Jones; Liam J McGuffin; Jonathan M Gibbins
Journal:  Blood       Date:  2021-02-11       Impact factor: 22.113

Review 7.  Physiological and pathological roles of protein kinase A in the heart.

Authors:  Yuening Liu; Jingrui Chen; Shayne K Fontes; Erika N Bautista; Zhaokang Cheng
Journal:  Cardiovasc Res       Date:  2022-01-29       Impact factor: 10.787

8.  Modulation of myocardial contraction by peroxynitrite.

Authors:  Mark J Kohr; Steve R Roof; Jay L Zweier; Mark T Ziolo
Journal:  Front Physiol       Date:  2012-12-12       Impact factor: 4.566

9.  Diesterified nitrone rescues nitroso-redox levels and increases myocyte contraction via increased SR Ca(2+) handling.

Authors:  Christopher J Traynham; Steve R Roof; Honglan Wang; Robert A Prosak; Lifei Tang; Serge Viatchenko-Karpinski; Hsiang-Ting Ho; Ira O Racoma; Dominic J Catalano; Xin Huang; Yongbin Han; Shang-U Kim; Sandor Gyorke; George E Billman; Frederick A Villamena; Mark T Ziolo
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

10.  Oxidative stress induced mitochondrial protein kinase A mediates cytochrome c oxidase dysfunction.

Authors:  Satish Srinivasan; Joseph Spear; Karunakaran Chandran; Joy Joseph; Balaraman Kalyanaraman; Narayan G Avadhani
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.